Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin vs other oral antidiabetic drugs in inadequately controlled type 2 diabetes
ChiCTR-OIN-16009294Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: Composite treatment response at 12 weeks. Planned start Oct 2016; status: not yet recruiting.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-OIN-16009294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-16009294.